Source: Annual Congress 2009 - COPD comorbidities: translational approaches
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Pre-clinical models of COPD and its comorbidities. Annual Congress 2009 - COPD comorbidities: translational approaches

Member's Comments

No comment yet.

Related content which might interest you: Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 COPD and comorbidities Source: Annual Congress 2009 - COPD comorbidities: translational approaches Year: 2009 Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Translational models in asthma and COPD Source: International Congress 2016 – Closing the gap: novel translational research strategies Year: 2016 Molecular and clinical diseasome of comorbidities in exacerbated COPD patients Source: Eur Respir J 2015; 46: 1001-1010 Year: 2015 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Predictive factors for exacerbation and re-exacerbation in COPD: Results from the Swiss COPD cohort Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models Source: International Congress 2015 – COPD: interesting notes Year: 2015 Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Clinical and functional effectiveness of roflumilast in severe COPD patients Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Exacerbations of chronic obstructive pulmonary disease (COPD): Correlation of hospitalization days with epidemiological and clinical parameters Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010